Osteopore Limited

Equities

OSX

AU0000053324

Medical Equipment, Supplies & Distribution

Market Closed - Australian S.E. Other stock markets 02:10:37 2024-05-17 am EDT			5-day change	1st Jan Change
0.079 ^AUD	+5.33%		+2.60%	-88.03%

May. 14	Osteopore Partners SingHealth to Establish Global Center of Excellence; Shares Surge 22%	MT
Apr. 23	Australian Shares Rise on Business Activity Growth; Osteopore Soars 127%	MT

Osteopore Limited Announces the Resignation of Carl Runde as Chief Financial Officer

January 17, 2022 at 06:05 pm EST

Osteopore Limited informed shareholders of the resignation of Chief Financial Officer ("CFO"), Carl Runde, allowing Mr. Runde to pursue other opportunities. Mr. Runde will continue as Osteopore's CFO until the completion of Osteopore's 2021 full year financial results.

Latest news about Osteopore Limited

Osteopore Partners SingHealth to Establish Global Center of Excellence; Shares Surge 22%	May. 13	MT
Australian Shares Rise on Business Activity Growth; Osteopore Soars 127%	Apr. 23	MT
Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194%	Apr. 22	MT
Osteopore Secures Extension for Bridging Loan Maturity	Apr. 10	MT
Osteopore Achieves 97% Take Up on Entitlement Offer to Raise AU$2.9 Million	Apr. 05	MT
Osteopore Secures Singapore, Vietnam Market Approvals for Orthopedic Products	Mar. 26	MT
Osteopore Completes Clinical Trial of Customized Scaffolds for Bone Reconstruction	Mar. 26	MT
Osteopore Consolidates Capital	Mar. 03	MT
Osteopore Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Slowing Domestic Inflation Buoy Australian Shares to Eight-Day Winning Streak	Jan. 31	MT
Osteopore Posts 61% Jump in Q4 Revenue; Shares Rise 6%	Jan. 31	MT
Osteopore Surpasses Sales of 100,000 Implants Globally	Jan. 28	MT
Osteopore Enters Bridging Loan Agreement with Advance Opportunities Fund I	Dec. 28	MT
Osteopore Limited announced that it expects to receive SGD 1 million in funding	Dec. 27	CI
Osteopore Secures Clearance to Supply Neurosurgery Products to Hainan, China	Dec. 17	MT
Osteopore in Talks to Distribute Products in China	23-09-13	MT
Osteopore Limited Announces Resignation of Deborah Ho as Joint Company Secretary	23-09-04	CI
Osteopore Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Osteopore Signs Deal to Commercialize Products in China; Shares Rise 4%	23-07-24	MT
Osteopore Promotes Operating, Technology Chief to CEO	23-07-18	MT
Osteopore Limited Announces Executive Changes	23-07-17	CI
Osteopore Limited Appoints Hon. Michael Keenan as A Non-Executive Director	23-07-17	CI
Osteopore Joins Forces to Commercialize Implant Products in China; Shares Rally 11%	23-06-07	MT
Osteopore's Mesh Product Gets Reimbursement Approval from South African Insurer; Shares Gain 7%	23-05-16	MT
Osteopore Limited Announces Change of Registered Office Address	23-05-05	CI

Chart Osteopore Limited

Duration

Period

More charts

Company Profile

Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Companyâs patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Companyâs Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
OSTEOPORE LIMITED	-88.03%	5.46M
ABBOTT LABORATORIES	-5.36%	182B
MEDTRONIC PLC	+3.50%	114B
BECTON, DICKINSON AND COMPANY	-3.17%	68.38B
DEXCOM, INC.	+5.97%	52.46B
CENCORA, INC.	+7.98%	44.25B
HOYA CORPORATION	+7.52%	43.55B
METTLER-TOLEDO INTERNATIONAL, INC.	+24.98%	32.69B
TERUMO CORPORATION	+17.85%	26.73B
WEST PHARMACEUTICAL SERVICES, INC.	-0.36%	25.79B

Other Medical Equipment, Supplies & Distribution